Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.AMEH · Entity 4538 | Chief Financial Officer | March 31, 2022 | April 05, 2022 |
| BIOMERICA INCBMRA · Entity 8171 | Director | August 26, 2026 | August 27, 2026 |
| MusclePharm CorpMSLP · Entity 125097 | Chief Accounting Officer | June 17, 2022 | June 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date March 31, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,844 |
Reported balance
After 2022-03-31 transaction · row 1
1 source rowRow 1 · 2022-03-31 · Tax withholding · Disposed 469 · Balance 20,844 F1: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2022.
BIOMERICA INC
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 38,750 |
Reported balance
After 2026-08-26 transaction · row 1
1 source rowRow 1 · 2026-08-26 · Purchase · Acquired 6,250 · Balance 38,750 F1: On August 26, 2026, the reporting person acquired 6,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 26, 2026, the reporting person acquired 6,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers.
MusclePharm Corp
Report date June 17, 2022 · Filed June 22, 2022
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 27, 2026 21:26 UTC | BIOMERICA INC BMRA · Entity 8171 | PurchaseCommon stock | 6,250 | $1.60 | $10,000.00 |
DisclosureSEC source: 0001493152-26-040448 · ownership.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,750 F1 · shares: On August 26, 2026, the reporting person acquired 6,250 shares of the Issuer's common stock at a purchase price of $1.60 per share in private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated August 20, 2026, by and among certain institutional and individual investors identified on the signature pages thereto, which included among others B. Riley Principal Capital, LLC and certain members of the Company's Board of Directors and executive officers. Read SEC document |
| December 12, 2025 Filed Jan 28, 2026 22:40 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantCommon stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-004083 · ownership.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 F1 · shares: Award of restricted stock under the 2024 Stock Incentive Plan. The award of restricted stock will vest in full on the one-year anniversary of December 12, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 01:39 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 469 | $48.47 | $22,732.43 |
DisclosureSEC source: 0001250853-22-000053 · primary_doc.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,844 F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2022. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:14 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 2,802 | $50.71 | $142,089.42 |
DisclosureSEC source: 0001250853-22-000039 · primary_doc.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,313 F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of certain restricted stock awards which vested on February 3, 2022. Read SEC document |
| March 31, 2021 Filed Apr 3, 2021 00:29 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 555 | $27.09 | $15,034.95 |
DisclosureSEC source: 0001250853-21-000046 · primary_doc.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,115 F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2021. Read SEC document |
| March 08, 2021 Filed Mar 8, 2021 19:49 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 8,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-21-000037 · primary_doc.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,670 Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 23:54 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 3,103 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001250853-21-000025 · primary_doc.xml · derivative · entry 2 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,103 Underlying: Common Stock · 3,103 shares Expires 2026-02-02 F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the options shall vest in three equal annual installments over the next three years, commencing with first anniversary of February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 23:54 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 6,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001250853-21-000025 · primary_doc.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,064 Read SEC document |
| June 11, 2020 Filed Jun 13, 2020 00:02 UTC | Astrana Health, Inc. AMEH · Entity 4538 | PurchaseCommon Stock | 2,040 | $14.90 | $30,396.00 |
DisclosureSEC source: 0001250853-20-000054 · primary_doc.xml · nonDerivative · entry 2 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,197 Read SEC document |
| March 31, 2020 Filed Jun 13, 2020 00:02 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 555 | $12.92 | $7,170.60 |
DisclosureSEC source: 0001250853-20-000054 · primary_doc.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,157 F1 · kind: This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award which vested on March 31, 2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:12 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 4,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012613 · tm207161d5_4.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · CFO & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,712 F1 · kind: Restricted shares of Common Stock of Apollo Medical Holdings, Inc. (the "Company") granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 22:09 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | OtherCommon Stock | 4,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012607 · tm207161d2_4a.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · CFO & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,639 F1 · kind: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan. F1 · acquired: This Amendment reports the rescission on February 5, 2020 ab initio of the entire grant on November 27, 2019 of restricted shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan. Read SEC document |
| November 27, 2019 Filed Dec 3, 2019 02:58 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 4,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-069173 · tm1924375-3_4.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,722 F1 · kind: Restricted shares of Apollo Medical Holdings, Inc.'s (the "Company") Common Stock granted under the Company's 2015 Equity Incentive Plan, subject to vesting one-third on March 31, 2020, one-third on March 31, 2021, and the final one-third on March 31, 2022. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 18:49 UTC | Astrana Health, Inc. AMEH · Entity 4538 | PurchaseCommon Stock | 2,040 | $14.72 | $30,028.80 |
DisclosureSEC source: 0001553350-19-000640 · ownership.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,639 Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 01:12 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock | 1,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001553350-19-000098 · ownership.xml · nonDerivative · entry 1 Chin Eric · CIK 0001751197 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,599 F1 · kind: All of the securities reported herein were granted fully vested pursuant to a restricted stock grant agreement in accordance with the Issuer's 2015 Equity Incentive Plan, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.